JNJ-56136379, an HBV Capsid Assembly Modulator, Is Well-Tolerated and Has Antiviral Activity in a Phase 1 Study of Patients With Chronic InfectionFabien Zoulim, Jeysen Yogaratnam, Oliver Lenz et al.|Gastroenterology|2020Cited by 116